Maharashtra Elections: The political climate takes another drastic turn in Maharashtra as Zeeshan Siddique, the son of the Late Baba Siddique joins the NCP of Maharashtra Deputy Chief Minister Arjit Pawar ahead of the upcoming Maharashtra Assembly elections. He will contest from Vandre East Constituency.
The move came in light of the execution of his father by three assailants who are believed to be a part of Lawrence Bishnoi’s gang. After 13 days of Baba Siddique’s death, Zeeshan became a part of NCP after he was expelled from Congress for allegedly cross-voting in the Maharashtra legislative council elections. He has denied these allegations.
Here is everything you need to know about Zeeshan Siddique.
Born to the former minister of Maharashtra, Late Baba Siddique, and Shehzeen Siddique on 3 October 1992, Zeeshan Siddique is a young politician from Maharashtra. He was a part of the Indian National Congress but has recently joined the NCP led by Arjit Pawar.
He has been serving as the President of the Mumbai Youth Congress as well.
His academic qualifications back his vigor in politics and leadership skills. He graduated in Management Studies from M.M.K. College, University of Mumbai, and holds a Master’s degree in Global Management and Public Leadership from Regent's University London, United Kingdom.
Zeeshan Siddique ventured into Indian politics in 2019, contesting the MLA elections from his father’s constituency, Bandra East, Mumbai. The then 34-year-old was contesting against Shiv Sena’s Vishwanath Mahadeshwar, the then Mayor of Mumbai, from the seat his father had emerged victorious thrice. Despite the palpable pressure, he won the elections.
He has now switched sides with his joining of NCP. calling it an emotional moment he also recalled the time he won from the Vandre East constituency on a Congress ticket in 2019.
The political trajectory of Siddique is not without controversy. In 2021, Zeeshan Siddique and actor Sonu Sood were under the scrutiny of the Bombay High Court for their alleged possession of the antiviral drug Remdesivir at the time of the global Pandemic.